Open access data will soon require business models, says Deepak Singh at bbgm. And he's not the only one to believe this, as he points out several posts that speak to putting open data into a useable (and accessible) framework as being key to building upon it. The best way to do this, of course, is to set up a business and charge a fee. Re-iterates Singh, "Data, especially open data, needs to be accompanied by APIs that allow the data to be accessed in a number of formats.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.